SEC Form D filing
Lyogenesis Holdings, LLC
Biotech · Series A · Regulation D 506(b) · WI · Filed May 12, 2026
Offering amount
$5.0M
Exemption
Reg D 506(b)
Issuer state
WI
Filing date
May 12, 2026
Signature date
—
CIK
0002134839
Summary
Lyogenesis is tissue-engineering biotech firm; $5M offering typical for series-a biotech stage.
Source
FormDFlow indexes public-disclosure data from SEC EDGAR. Nothing on this page is investment advice.